Reaction
Autologous Haematopoietic Stem Cell Transplant reporting signals
As of the last recalculation, Autologous Haematopoietic Stem Cell Transplant appears in 87 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is OBINUTUZUMAB (PRR 242.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Obinutuzumab | 14 | 242.5 | 242.7 |
| Ifosfamide | 16 | 218.1 | 218.2 |
| Daratumumab | 25 | 209.7 | 209.8 |
| Venetoclax | 33 | 205.9 | 206.1 |
| Temozolomide | 14 | 189.2 | 189.4 |
| Thiotepa | 6 | 161.4 | 161.5 |
| Melphalan | 13 | 160.6 | 160.7 |
| Azacitidine For | 9 | 131.9 | 132.0 |
| Ofatumumab | 14 | 119.9 | 120.0 |
| Polatuzumab Vedotin | 4 | 102.7 | 102.8 |
| Azacitidine | 9 | 80.8 | 80.9 |